Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07298135 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults
A NA study of Blood Glucose Control, sponsored by Olipop, PBC.
- Recruiting
- Registry status
- NA
- Development phase
- 224
- Enrollment target
- 1
- Study location
NCT07298135 is a NA study of Blood Glucose Control that is actively recruiting participants, run by Olipop, PBC. The registered enrollment target is 224 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07298135, a NA study of Blood Glucose Control, is actively recruiting participants, sponsored by Olipop, PBC.
- RECRUITING
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to evaluate the chronic effects of replacing traditional non-diet soda with a prebiotic soda on biomarkers associated with glycemic control in adults with glucose dysregulation who are habitual consumers of traditional soda.
Conditions Studied
Interventions
- BEHAVIORAL Active Control
- BEHAVIORAL Prebiotic Soda
Study Locations (1)
Massachusetts
- Lindus Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07298135
The ClinicalTrials.gov registry entry for NCT07298135 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olipop, PBC, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Glucose Control appearing as the primary indexed condition, and to 2 interventions - of which Active Control is the first listed.
NCT07298135 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07298135 about?
NCT07298135 is a clinical study titled "A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults". The main objective of this study is to evaluate the chronic effects of replacing traditional non-diet soda with a prebiotic soda on biomarkers associated with glycemic control in adults with glucose dysregulation who are habitual consumers of traditional soda.
What is the current status of trial NCT07298135?
This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2025-12-17. Estimated completion is 2026-05.
What conditions does trial NCT07298135 study?
This clinical trial studies the following conditions: Blood Glucose Control.
What interventions are being tested in trial NCT07298135?
The interventions under investigation include: Active Control (BEHAVIORAL), Prebiotic Soda (BEHAVIORAL).
Who is sponsoring clinical trial NCT07298135?
This trial is sponsored by Olipop, PBC, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07298135 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.